NO142625C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye piperazinderivater - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye piperazinderivater

Info

Publication number
NO142625C
NO142625C NO770374A NO770374A NO142625C NO 142625 C NO142625 C NO 142625C NO 770374 A NO770374 A NO 770374A NO 770374 A NO770374 A NO 770374A NO 142625 C NO142625 C NO 142625C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
piperazine derivatives
active new
analogy procedure
Prior art date
Application number
NO770374A
Other languages
English (en)
Norwegian (no)
Other versions
NO770374L (no
NO142625B (no
Inventor
Richard Cyrus
Manfred Raschack
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of NO770374L publication Critical patent/NO770374L/no
Publication of NO142625B publication Critical patent/NO142625B/no
Publication of NO142625C publication Critical patent/NO142625C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO770374A 1976-02-07 1977-02-04 Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye piperazinderivater NO142625C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762604845 DE2604845A1 (de) 1976-02-07 1976-02-07 Neue piperazinderivate

Publications (3)

Publication Number Publication Date
NO770374L NO770374L (no) 1977-08-09
NO142625B NO142625B (no) 1980-06-09
NO142625C true NO142625C (no) 1980-09-17

Family

ID=5969327

Family Applications (1)

Application Number Title Priority Date Filing Date
NO770374A NO142625C (no) 1976-02-07 1977-02-04 Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye piperazinderivater

Country Status (25)

Country Link
US (1) US4079137A (de)
JP (1) JPS52105186A (de)
AT (1) AT355578B (de)
AU (1) AU504526B2 (de)
BE (1) BE850492A (de)
CA (1) CA1094560A (de)
CH (1) CH631448A5 (de)
CS (1) CS201544B2 (de)
DD (1) DD128133A5 (de)
DE (1) DE2604845A1 (de)
DK (1) DK138891C (de)
ES (1) ES455691A1 (de)
FI (1) FI63226C (de)
FR (1) FR2340311A1 (de)
GB (1) GB1550545A (de)
HU (1) HU173483B (de)
IE (1) IE44339B1 (de)
IL (1) IL51316A (de)
LU (1) LU76706A1 (de)
NL (1) NL7700841A (de)
NO (1) NO142625C (de)
PL (1) PL105526B1 (de)
PT (1) PT66154B (de)
SE (1) SE7701187L (de)
ZA (1) ZA77248B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341698A (en) * 1979-06-21 1982-07-27 Richardson-Merrell Inc. Enkaphalin derivatives
US4483988A (en) * 1980-03-14 1984-11-20 Richardson Merrell Inc. Substituted derivatives of 4-t-alkoxycarbonyl-piperazin-2-ones
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia
CA2588685A1 (en) * 2004-12-06 2006-06-15 Sciclone Pharmaceuticals, Inc. Alpha thymosin peptides as cancer vaccine adjuvants
US20080300166A1 (en) * 2007-06-01 2008-12-04 Sciclone Pharmaceuticals, Inc. Treatment of Melanoma with Alpha Thymosin Peptides
WO2009075813A1 (en) * 2007-12-12 2009-06-18 Sciclone Pharmaceuticals, Inc. Treatment of melanoma with alpha thymosin peptides in combination with antibodies against cytotoxic t lymphocyte-associated antigen 4 (ctla4)
EP2240194A4 (de) * 2007-12-13 2011-12-21 Sciclone Pharmaceuticals Inc Melanombehandlung mit alpha-thymosin-peptiden in kombination mit einem kinase-inhibitor
WO2009079338A1 (en) * 2007-12-14 2009-06-25 Sciclone Pharmaceuticals, Inc. Treatment of melanoma with alpha thymosin peptides in combination with an antineoplastic heat shock apoptosis activator (hsaa)
US8829173B2 (en) 2008-09-26 2014-09-09 Tocagen Inc. Recombinant vectors
WO2010129947A2 (en) * 2009-05-08 2010-11-11 Sciclone Pharmaceuticals, Inc. Alpha thymosin peptides as vaccine enhancers
TWI749433B (zh) 2014-10-21 2021-12-11 開曼群島商賽生製藥國際有限公司 用免疫刺激物治療癌症

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472856A (en) * 1967-05-29 1969-10-14 Sterling Drug Inc 1-((thianaphthenyl)-lower-alkyl)-4-substituted-piperazines
DE2438725A1 (de) * 1974-08-12 1976-02-26 Knoll Ag Piperazinderivate
US4031216A (en) * 1974-08-12 1977-06-21 Knoll A.G. Chemische Fabriken 3-(3,4-Dialkoxy-benzyl)-3-methyl-piperazines

Also Published As

Publication number Publication date
FR2340311A1 (fr) 1977-09-02
CH631448A5 (de) 1982-08-13
HU173483B (hu) 1979-05-28
CS201544B2 (en) 1980-11-28
IE44339B1 (en) 1981-10-21
NO770374L (no) 1977-08-09
IL51316A0 (en) 1977-03-31
ZA77248B (en) 1977-11-30
US4079137A (en) 1978-03-14
FI63226B (fi) 1983-01-31
FR2340311B1 (de) 1980-02-08
LU76706A1 (de) 1977-06-28
NL7700841A (nl) 1977-08-09
JPS52105186A (en) 1977-09-03
AU2195277A (en) 1978-08-10
SE7701187L (sv) 1977-08-08
AU504526B2 (en) 1979-10-18
GB1550545A (en) 1979-08-15
DK138891B (da) 1978-11-13
FI770398A (de) 1977-08-08
PT66154B (fr) 1978-07-07
FI63226C (fi) 1983-05-10
DK49077A (da) 1977-08-08
BE850492A (fr) 1977-07-18
DD128133A5 (de) 1977-11-02
PT66154A (fr) 1977-03-01
DE2604845A1 (de) 1977-08-18
IE44339L (en) 1977-08-07
AT355578B (de) 1980-03-10
DK138891C (da) 1979-04-23
PL105526B1 (pl) 1979-10-31
IL51316A (en) 1980-12-31
CA1094560A (en) 1981-01-27
NO142625B (no) 1980-06-09
ATA68177A (de) 1979-08-15
ES455691A1 (es) 1978-01-01

Similar Documents

Publication Publication Date Title
NO151085C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive peptidylargininaldehydderivater
NO153136C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive naftyridinderivater.
NO160211C (no) Analogifremgangsmaate til fremstilling av nye terapeutisk virksomme cefemderivater.
NO154919C (no) Analogifremgangsmaate ved fremstilling av nye kinazolinderivater.
NO147148C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive fenyletanolaminderivater
NO152841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 4-aroylimidazol-2-oner.
NO149733C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive acylderivater av carnitin
NO150884C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive imidazotiazolderivater
NO148848C (no) Analogifremgangsmaate ved fremstilling av nye antibiotisk aktive spiroimidazolidin-rifamyciner
NO148642C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye prostacyclinderivater
NO148416C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-, morfolin- og tiazan-derivater
NO154426C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive trans-3-(4-okso-4h-kinazolin-3-yl)-2-propensyrederivater.
NO152654C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive derivater av 7-acylamido-3-cephem-4-karboksylsyre
NO146095C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinazolin-derivater
NO145791C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive imidazolderivater
NO145842C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive indolizinderivater
NO148926C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, nye merkaptoimidazolderivater
NO153725C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 4-(nafthylmethyl)-piperidin-derivater.
NO142625C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye piperazinderivater
NO145618C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive spiro-(1,3-dioxolan-4,3`-kinuclidin-forbindelser
NO150882C (no) Analogifremgangsmaate ved fremstilling av nye 1,4-benzoksazin-derivater
NO154920C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye pyridothienotriaziner.
NO143026C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk virksomme halogenderivater
NO150279C (no) Analogifremgangsmaate til fremstilling av nye terapeutisk virksomme benzopyranderivater
NO154396C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive halovincamonderivater.